Joseph Rager
3PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Sep 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers.Michael Hulse, Min Wang, Chaoyi Xu
|Jan 24, 2025
Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.Jan Philipp Bewersdorf, Xiaoli Mi, Bin Lu
|Oct 20, 2023
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.Jack Carter, Michael Hulse, Monisha Sivakumar
Pageof 1
Frequent Collaborators
2 joint publications
Jack Carter
2 joint publications
Monisha Sivakumar
2 joint publications
Jessica Burtell
2 joint publications
Koichi Ito
2 joint publications
Min Wang
2 joint publications
Anjana Agarwal
2 joint publications
Komali Vykuntam
2 joint publications
Peggy Scherle
2 joint publications
Neha Bhagwat
2 joint publications
Bruce Ruggeri
